Featured
The In Vivo Paradigm Shift: How AI-Designed Lipid Nanoparticles are Rewiring Solid Tumor Economics
The FDA's breakthrough designation for an AI-designed, in vivo CRISPR therapy targeting pancreatic cancer marks a structural shift from bespoke ex viv...
Read Full Story →